2m 2m 2m 2m 2m 2m 2m
ABSCI (ABSI)
NASDAQ
$9.49-$0.55 (-5.49%)
Price as of Oct 22, 2026 7:57 PM EDT- $1.7BMarket Cap
- 134.31%1-Year Change
- BiotechnologyIndustry
ABSCI (ABSI)
$9.49-$0.55 (-5.49%)
ABSI | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $10.04 | ||
Change | +$0.97 (+10.69%) | ||
Open | $9.24 | ||
High | $10.21 | ||
Low | $9.11 | ||
Previous Close | $9.07 | ||
Volume | 5,354,720 | ||
30-Day Average Volume | 4,202,497 | ||
1-Week Change | 14.87% | ||
1-Month Change | 2.24% | ||
1-Year Change | 134.31% | ||
3-Year Change | 696.83% | ||
5-Year Change | -15.35% | ||
Fundamentals | |||
Shares Outstanding | 171.6M | ||
Total Assets | $268.9M | ||
Market Cap | $1.7B | ||
Enterprise Value | $1.6B | ||
Period: QTR TTM FY | |||
Revenue | $318,000.00 | ||
Net Income | -$33.2M | ||
Free Cash Flow | -$27.6M | ||
EBIT | -$33.2M | ||
EBITDA | -$30.5M | ||
Net Working Capital | $188.7M | ||
EPS | -$0.21 | ||
Enterprise Value/EBITDA | -53 | ||
Enterprise Value/Revenue | 5,080 | ||
P/B | 7 | ||
P/E | -48 | ||
PEG | 5 | ||
Price/Free Cash Flow | -63 | ||
Price/Operating Cash Flow | -63 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue